AIHC Capital Management Ltd

Fundamental diversified ★Signal healthcare specialist (100%) CIK 2103725
Long book
$119.7M
Q1 2026
Positions
5
Top-10 weight
100%
concentration
Last quarter
+61.1%
SPY +14.8%
Turnover
43%
of book per quarter

Strategy in plain words

auto-generated from filings

AIHC Capital Management Ltd is a diversified fundamental manager, specialised in healthcare (100% of the long book), running a $119.7M US long book across 5 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: REVOLUTION MEDICINES INC, ORIC PHARMACEUTICALS INC, NOVABRIDGE BIOSCIENCES, COGENT BIOSCIENCES INC, KORRO BIO INC.

We rate its filings as signal-bearing: position changes reflect genuine views.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q4 2025
+19.6%
Q1 2026
+61.1%

Sector allocation

Healthcare
100%

Long book by quarter

$106.7M
Q4 2025
$119.7M
Q1 2026

What does AIHC Capital own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
RVMD REVOLUTION MEDICINES INCHealthcare829.0K$80.6M67.4%-7.9%
ORIC ORIC PHARMACEUTICALS INCHealthcare2.5M$31.2M26.0%New
COGT COGENT BIOSCIENCES INCHealthcare51.4K$2.0M1.7%-48.6%
KRRO KORRO BIO INCHealthcare30.3K$343K0.3%Held

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 8, 20265$119.7M canonicalSEC ↗
Q4 202513F-HRFeb 5, 20266$106.7M canonicalSEC ↗